Deadly Herpes Virus Could be Treated with a Drug Used Against AIDS

Barcelona, Spain (Scicasts) – Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have discovered that raltegravir, the drug approved in 2007 for the treatment of AIDS which is sold by Merck under the name Isentress, cancels the function of an essential protein for the replication of the human cytomegalovirus, the most deadly and widespread herpes virus and the cause of serious defects in neonates.
The study, headed by Miquel Coll – the coordinator of the Structural and Computational Biology Programme, was published in the journal Proceedings of the National Academy of Sciences (PNAS), and is the first step towards the development of a drug against the entire herpesvirus family, according to the press report.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s